scholarly journals Cerebrospinal fluid fatty acid binding protein 3: A screening biomarker for preclinical Alzheimer’s disease

2020 ◽  
Vol 16 (S5) ◽  
Author(s):  
Kunal Dhiman ◽  
Ralph N Martins ◽  
Veer Bala Gupta
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cerebrospinal Fluid ◽  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Preclinical Alzheimer’S Disease ◽  
Fatty Acid Binding ◽  
Acid Binding Protein

scholarly journals Cerebrospinal fluid heart fatty acid‐binding protein as a predictive biomarker of neurodegeneration in Alzheimer’s disease

2021 ◽  
Vol 7 (1) ◽  
pp. 44-55
Author(s):  
Lu Pan ◽  
Ya-Nan Ou ◽  
Lin Tan ◽  
Lan Tan ◽  
Jin-Tai Yu
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cerebrospinal Fluid ◽  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Predictive Biomarker ◽  
Fatty Acid Binding ◽  
Acid Binding Protein ◽  
T Tau

Objective This study aims to investigate whether the heart fatty acid‐binding protein (HFABP) in the cerebrospinal fluid (CSF) was a potential predictive biomarker for Alzheimer’s disease (AD). Methods We evaluated the associations of CSF HFABP levels with core biomarkers, cognition, and brain structure in a sample population ( n = 302) from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. Multiple linear regression and mixed‐effects models were employed in the analyses. AD progression was assessed using the Kaplan–Meier survival analysis. Results CSF HFABP was higher in patients with mild cognitive impairment and AD than the normal controls ( p < 0.001) and was particularly higher in those with amyloid‐β (Aβ) pathologic features. CSF HFABP was associated with higher baseline CSF t‐tau ( p < 0.001), CSF p‐tau ( p < 0.001), and CSF t‐tau/Aβ42 and CSF p‐tau/Aβ42 ( p < 0.01). Moreover, CSF HFABP was found to play predictive roles in hippocampal atrophy ( p < 0.01), cognitive decline ( p < 0.05), and the risk of AD ( p < 0.001). Conclusion Our findings suggest that CSF HFABP can be a predictive biomarker of AD.

scholarly journals P4-002: Cerebrospinal heart fatty-acid-binding protein as a biomarker for Alzheimer's disease

2013 ◽  
Vol 9 ◽  
pp. P705-P705
Author(s):  
Carlos Cruchaga ◽  
Oscar Harari ◽  
John Kauwe ◽  
Kelly Bales ◽  
Eve H. Pickering ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Fatty Acid Binding ◽  
Acid Binding Protein

CSF levels of heart fatty acid binding protein in Parkinson's and Alzheimer's disease

2016 ◽  
Vol 22 ◽  
pp. e33 ◽  
Author(s):  
Davide Chiasserini ◽  
Leonardo Biscetti ◽  
Paolo Eusebi ◽  
Lucia Farotti ◽  
Nicola Tambasco ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Fatty Acid Binding ◽  
Acid Binding Protein ◽  
Csf Levels

CSF Levels of Heart Fatty Acid Binding Protein are Altered During Early Phases of Alzheimer's Disease

2011 ◽  
Vol 22 (4) ◽  
pp. 1281-1288 ◽  
Author(s):  
Davide Chiasserini ◽  
Lucilla Parnetti ◽  
Ulf Andreasson ◽  
Henrik Zetterberg ◽  
David Giannandrea ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Fatty Acid ◽  
Fatty Acid Binding Protein ◽  
Binding Protein ◽  
Fatty Acid Binding ◽  
Acid Binding Protein ◽  
Csf Levels ◽  
Early Phases

scholarly journals Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium

2020 ◽  
Vol 77 (1) ◽  
pp. 183-190
Author(s):  
Bjørn Erik Neerland ◽  
Nathalie Bodd Halaas ◽  
Ane Victoria Idland ◽  
Kristi Henjum ◽  
Kaj Blennow ◽  
...  
Keyword(s):  
Cerebrospinal Fluid ◽  
Fatty Acid ◽  
Hip Fracture ◽  
Fatty Acid Binding Protein ◽  
Neuronal Damage ◽  
Binding Protein ◽  
Fatty Acid Binding ◽  
Cognitively Normal ◽  
Acid Binding Protein ◽  
Normal Controls

Background: Delirium is associated with dementia and thus biomarkers reflecting neurodegeneration are of interest. Fatty acid-binding protein 3 (FABP3) is a cytoplasmic neuronal protein that has been isolated from the brain. It is released following brain injury and concentrations in cerebrospinal fluid (CSF) are also higher in neurodegenerative disorders such as Alzheimer’s disease (AD). Objective: To examine the relationship between CSF FABP3 concentration and delirium in hip fracture patients compared to a group of cognitively normal controls. Methods: CFS FABP3 concentration was measured in 128 hip fracture patients with (n = 71) and without (n = 57) delirium, and in cognitively unimpaired adults ≥64 years (n = 124) undergoing elective surgery. Results: CSF FABP3 (pg/ml) concentration (median (IQR)) was higher in hip-fracture patients compared to cognitively normal controls (5.7 (4.2–7.7) versus 4.5 (3.4–6.1), p < 0.001). There was a significant weak correlation between age and CSF FABP3 (ρ= 0.3, p < 0.001). After adjustment for age, the association between CSF FABP3 and hip-fracture was no longer statistically significant (β= 0.05, p = 0.5). There were no significant differences in CSF FABP3 concentration between hip fracture patients with (5.4 (4.1–8.2)) and without (5.8 (4.2–7.2)) delirium. CSF FABP3 concentration correlated positively with CSF AD biomarkers p-tau (ρ= 0.7, p < 0.01) and t-tau (ρ= 0.7, p < 0.01). Conclusion: CSF FABP3 concentrations were higher in hip fracture patients compared with cognitively normal older adults, indicating ongoing age-related neurodegeneration in these patients. There were no differences of CSF FABP3 concentrations across delirium groups, suggesting that neuronal damage or degeneration reflected by FABP3 may not be directly linked to delirium pathophysiology.

Sign in / Sign up

Export Citation Format

Share Document